In several cell lines, including uveal melanoma, endothelial, and corneal epithelial cells, activation of TRPM8 inhibited the VEGF transactivation of TRPV1 and the consequent pro-tumorigenic effects mediated by the VEGFR. Here, TRPM8 is linked to uveal melanoma.